Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 283, Issue 5 52-5, 2002, Pages

  Wu, M F ^a,b   John, J ^a,b   Maidment, N ^b   Lam, H A ^b   Siegel, J M ^a,b  

^a Greater Los Angeles Healthcare System   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cerebrospinal fluid; Feeding; Locomotor activity; Orexin

Indexed keywords

NEUROPEPTIDE; OREXIN; OREXIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MOVEMENT; CEREBROSPINAL FLUID; CONTROLLED STUDY; DOG; EATING; FEEDING; FEMALE; FOOD DEPRIVATION; HORMONE RELEASE; MALE; MOTOR ACTIVITY; NARCOLEPSY; NONHUMAN; PRIORITY JOURNAL; SLEEP DEPRIVATION; WAKEFULNESS;

EID: 0036838544     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00207.2002     Document Type: Article

References (64)

1. Alam MN, Gong H, Alam T, Jaganath R, McGinty D, and Szymusiak R. Sleep-waking discharge patterns of neurons recorded in the rat perifornical lateral hypothalamic area. J Physiol 538: 619-631, 2002.
2. Aldrich MS. Diagnostic aspects of narcolepsy. Neurology 50, Suppl 1: S2-S7, 1998.
3. American Physiological Society. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol 283: R281-R283, 2002.
4. Bourgin P, Huitron-Resendiz S, Spier AD, Fabre V, Morte B, Criado JR, Sutcliffe JG, Henriksen SJ, and De Lecea L. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci 20: 7760-7765, 2000.
5. Cai XJ, Lister CA, Buckingham RE, Pickavance L, Wilding J, Arch JR, Wilson S, and Williams G. Down-regulation of orexin gene expression by severe obesity in the rats: Studies in zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone. Mol Brain Res 77: 131-137, 2000.
6. Chemelli RM, Willie JT, Sinton C, Elmquist J, Scammell T, Lee C, Richardson J, Williams S, Xiong Y, Kisanuki Y, Fitch T, Nakazato M, Hammer R, Saper C, and Yanagisawa M. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation. Cell 98: 437-451, 1999.
7. De Lecea L, Kilduff T, Peyron C, Gao XB, Foye PE, Danielson PE, Fukahara C, Battenberg ELF, Gautvik VT, Barlett FS, Frankel WN, van den Pol AN, Bloom F, Gautvik KM, and Sutcliffe JG. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95: 322-327, 1998.
8. Dube MG, Kalra SP, and Kalra PS. Food intake elicited by central administration of orexins/hypocretins: Identification of hypothalamic sites of action. Brain Res 842: 473-477, 1999.
9. Edwards CM, Abusnana S, Sunter D, Murphy KG, Ghatei MA, and Bloom SR. The effect of the orexins on food intake: Comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J Endocrinol 160: R7-R12, 1999.
10. Estabrooke IV, McCarthy MT, Ko E, Chou TC, Chemelli RM, Yanagisawa M, Saper CB, and Scammell TE. Fos expression in orexin neurons varies with behavioral state. J Neurosci 21: 1656-1662, 2001.
11. Evarts EV. Temporal patterns of discharge of pyramidal tract neurons during sleep and waking in the monkey. J Neurophysiol 27: 152-171, 1964.
12. Fujiki N, Yoshida Y, Ripley B, Honda K, Mignot E, and Nishino S. Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation. Neuroreport 12: 993-997, 2001.
13. Gerashchenko D, Kohls MD, Greco M, Waleh NS, Salin-Pascual R, Kilduff TS, Lappi DA, and Shiromani PJ. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. J Neurosci 21: 7273-7283, 2001.
14. Griffond B, Risold PY, Jacquemard C, Colard C, and Fellmann D. Insulin-induced hypoglycemia increases preprohypocretin (orexin) mRNA in the rat lateral hypothalamic area. Neurosci Lett 262: 77-80, 1999.
15. Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S, Benham CD, Taylor SG, Routledge C, Hemmati P, Munton RP, Ashmeade TE, Shah AS, Hatcher JP, Hatcher PD, Jones DN, Smith MI, Piper DC, Hunter AJ, Porter RA, and Upton N. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 96: 10911-10916, 1999.
16. Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, Sugiyama F, Yagami K, Goto K, Yanagisawa M, and Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30: 345-354, 2001.
17. Ida T, Nakahara K, Katayama T, Murakami N, and Nakazato M. Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Res 821: 526-529, 1999.
18. Itoh T, Murai S, Nagahama H, Miyate H, Abe E, Fujiwara H, and Saito Y. Effects of 24-hr fasting on methamphetamine- and apomorphine-induced locomotor activities, and on monoamine metabolism in mouse corpus striatum and nucleus accumbens. Pharmacol Biochem Behav 35: 391-396, 1990.
19. Ivanov A and Aston-Jones G. Hypocretin/orexin depolarizes and decreases potassium conductance in locus coeruleus neurons. Neuroreport 11: 1755-1758, 2000.
20. st Annual Meeting, San Diego, CA, Nov. 11, 2001.
21. John J, Wu MF, and Siegel JM. Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs (Online). Sleep Res 3: 23-28, 2000 [http://www.sro.org/2000/John/23/].
22. Kastin AJ and Akerstrom V. Orexin A but not orexin B rapidly enters brain from blood by simple diffusion. J Pharmacol Exp Ther 289: 219-223, 1999.
23. Kiyashchenko LI, Mileykovskiy BY, Lai YY, and Siegel JM. Increased and decreased muscle tone with orexin (hypocretin) microinjections in the locus coeruleus and pontine inhibitory area. J Neurophysiol 85: 2008-2016, 2001.
24. Kiyashchenko LI, Mileykovskiy BY, Maidment N, Lam HA, Wu MF, John J, Peever J, and Siegel JM. Release of hypocretin (orexin) in waking and sleep states. J Neurosci 22: 5282-5286, 2002.
25. Kotz CM, Teske JA, Levine JA, and Wang CF. Feeding and activity induced by orexin A in the lateral hypothalamus in rats. Regul Pept 104: 27-32, 2002.
26. Kunii K, Yamanaka A, Nambu T, Matsuzaki I, Goto K, and Sakurai T. Orexins/hypocretins regulate drinking behaviour. Brain Res 842: 256-261, 1999.
27. Lammers GJ, Pijl H, Iestra J, Langius JA, Buunk G, and Meinders AE. Spontaneous food choice in narcolepsy. Sleep 19: 75-76, 1996.
28. Levitt DR and Teitelbaum P. Somnolence, akinesia, and sensory activation of motivated behavior in the lateral hypothalamic syndrome. Proc Natl Acad Sci USA 72: 2819-2823, 1975.
29. Lubkin M and Stricker-Krongrad A. Independent feeding and metabolic actions of orexins in mice. Biochem Biophys Res Commun 253: 241-245, 1998.
30. Lucas EA, Foutz AS, Dement WC, and Mitler MM. Sleep cycle organization in narcoleptic and normal dogs. Physiol Behav 23: 737-743, 1979.
31. Mabry PA and Campbell BA. Food-deprivation-induced behavioral arousal: Mediation by hypothalamus and amygdala. J Comp Physiol Psychol 89: 19-38, 1975.
32. Maidment NT and Evans CJ. Measurement of extracellular neuropeptides in the brain: Microdialysis linked to solid phase radioimmunossays with subfemptomole limits of detection. In: Microdialysis in the Neurosciences, edited by Robinson TE and Justice JB. New York: Elsevier Science, 1991, p. 275-303.
33. Mangels RA, Jetton AE, Powers JB, and Wade GN. Food deprivation and the facilitatory effects of estrogen in female hamsters: The LH surge and locomotor activity. Physiol Behav 60: 837-843, 1996.
34. Millea PJ and Holloway RL. Treating fibromyalgia. Am Fam Physician 62: 1575-1587, 2000.
35. Mittleman G and Valenstein ES. Ingestive behavior evoked by hypothalamic stimulation and schedule-induced polydipsia are related. Science 224: 415-417, 1984.
36. Mondal MS, Nakazato M, Date Y, Murakami N, Hanada R, Sakata T, and Matsukura S. Characterization of orexin-A and orexin-B in the microdissected rat brain nuclei and their contents in two obese rat models. Neurosci Lett 273: 45-48, 1999.
37. Moriguchi T, Sakurai T, Nambu T, Yanagisawa M, and Goto K. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia. Neurosci Lett 264: 101-104, 1999.
38. National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy, 1996.
39. Nishino S, Arrigoni J, Shelton J, Dement WC, and Mignot E. Desmethyl metabolites of serotonergic uptake inhibitors are more potent for suppressing canine cataplexy than their parent compounds. Sleep 16: 706-712, 1993.
40. Nowak KW, Mackowiak P, Switonska MM, Fabis M, and Malendowicz LK. Acute orexin effects on insulin secretion in the rat: In vivo and in vitro studies. Life Sci 66: 449-454, 2000.
41. Offenbacher M and Stucki G. Physical therapy in the treatment of fibromyalgia. Scand J Rheumatol Suppl 113: 78-85, 2000.
42. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, Nishino S, and Mignot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6: 991-997, 2000.
43. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, and Kilduff TS. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18: 9996-10015, 1998.
44. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, and Yanagisawa M. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573-585, 1998.
45. Schuld A, Hebebrand J, Geller F, and Pollmacher T. Increased body-mass index in patients with narcolepsy. Lancet 355: 1274-1275, 2000.
46. Shirasaka T, Nakazato M, Matsukura S, Takasaki M, and Kannan H. Sympathetic and cardiovascular actions of orexins in conscious rats. Am J Physiol Regul Integr Comp Physiol 277: R1780-R1785, 1999.
47. Siegel JM. Behavioral functions of the reticular formation. Brain Res Rev 1: 69-105, 1979.
48. Siegel JM. Narcolepsy: A key role for hypocretins (orexins). Cell 98: 409-412, 1999.
49. Siegel JM and Tomaszewski KS. Behavioral organization of reticular formation: Studies in the unrestrained cat. I. Cells related to axial, limb, eye, and other movements. J Neurophysiol 50: 696-716, 1983.
50. Siegel JM, Tomaszewski KS, and Wheeler RL. Behavioral organization of reticular formation: Studies in the unrestrained cat. II. Cells related to facial movements. J Neurophysiol 50: 717-723, 1983.
51. Sweet DC, Levine AS, Billington CJ, and Kotz CM. Feeding response to central orexins. Brain Res 821: 535-538, 1999.
52. Taheri S, Sunter D, Dakin C, Moyes S, Seal L, Gardiner J, Rossi M, Ghatei M, and Bloom S. Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA in the rat central nervous system. Neurosci Lett 279: 109-112, 2000.
53. Takahashi Y, Ebihara S, Nakamura Y, and Takahashi K. A model of human sleep-related growth hormone secretion in dogs: Effects of 3, 6, and 12 hours of forced wakefulness on plasma growth hormone, cortisol, and sleep stages. Endocrinology 109: 262-272, 1981.
54. Takahashi N, Okumura T, Yamada H, and Kohgo Y. Stimulation of gastric acid secretion by centrally administered orexin-A in conscious rats. Biochem Biophys Res Commun 254: 623-627, 1999.
55. Terao A, Peyron C, Ding J, Wurts SW, Edgar DM, Heller HC, and Kilduff TS. Prepro-hypocretin (prepro-orexin) expression is unaffected by short-term sleep deprivation in rats and mice. Sleep 23: 867-874, 2000.
56. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, and Siegel JM. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27: 469-474, 2000.
57. Tritos NA, Mastaitis JW, Kokkotou E, and Maratos-Flier E. Characterization of melanin concentrating hormone and preproorexin expression in the murine hypothalamus. Brain Res 895: 160-166, 2001.
58. Valenstein ES. Channeling of responses elicited by hypothalamic stimulation. J Psychiatr Res 8: 335-344, 1971.
59. Valenstein ES, Cox VC, and Kakolewski JW. Reexamination of the role of the hypothalamus in motivation. Psychol Rev 77: 16-31, 1970.
60. Van den Pol AN. Hypothalamic hypocretin (orexin): Robust innervation of the spinal cord. J Neurosci 19: 3171-3182, 1999.
61. Willie JT, Chemelli RM, Sinton CM, and Yanagisawa M. To eat or sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci 24: 429-458, 2001.
62. Wu MF, Gulyani S, Yao E, Mignot E, Phan B, and Siegel JM. Locus coeruleus neurons: Cessation of activity during cataplexy. Neuroscience 91: 1389-1399, 1999.
63. st Annual Meeting, San Diego, CA, Nov. 11, 2001.
64. Yamanaka A, Sakurai T, Katsumoto T, Yanagisawa M, and Goto K. Chronic intracerebroventricular administration of orexin-a to rats increases food intake in daytime, but has no effect on body weight. Brain Res 849: 248-252, 1999.